![](/img/cover-not-exists.png)
Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics
Motoshima, Kohei, Nakamura, Yoichi, Sano, Kazumi, Ikegami, Yoji, Ikeda, Takaya, Mizoguchi, Kosuke, Takemoto, Shinnosuke, Fukuda, Minoru, Nagashima, Seiji, Iida, Tetsuya, Tsukamoto, Kazuhiro, Kohno, ShVolume:
72
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-013-2307-6
Date:
December, 2013
File:
PDF, 227 KB
english, 2013